Akebia Announces Manuscript Highlighting Global Phase 3 INNO2VATE Program Rationale, Study Design and Baseline Characteristics Published in Peer-Reviewed Medical Journal by Seini Moimoi | Nov 16, 2020 | Portfolio News
Talaris Therapeutics Expands Leadership Team with Appointments of Accomplished Executives in Manufacturing, Portfolio Strategy and Clinical Operations by Seini Moimoi | Nov 12, 2020 | Portfolio News
Axonics® Announces Publication of Fecal Incontinence Study Results for Patients Treated with r-SNM® System by Seini Moimoi | Nov 10, 2020 | Portfolio News
Inozyme Pharma Appoints Kevin B. Johnson, Ph.D., MBA, as Senior Vice President, Regulatory Affairs by Seini Moimoi | Nov 9, 2020 | Portfolio News
Eargo to Announce Third Quarter 2020 Financial Results by Seini Moimoi | Nov 9, 2020 | Portfolio News
